Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Sequential intravenous and intracerebroventricular GD2-CAR T-cell therapy for H3K27M-mutated diffuse midline gliomas.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2024
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Journal: Nature
Published: June 19, 2024
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
Journal: EClinicalMedicine
Published: March 13, 2023
Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia.
Journal: Science advances
Published: April 20, 2022
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 09, 2021
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Journal: Nature
Published: August 02, 2021
Prospects and challenges for use of CAR T cell therapies in solid tumors.
Journal: Expert opinion on biological therapy
Published: March 04, 2020
Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia.
Journal: Current oncology reports
Published: January 31, 2020
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Journal: Journal for immunotherapy of cancer
Published: June 14, 2019
Last Updated: 09/26/2026